Furthermore, the combination of AFP, AFP-L3, and DCP outperformed a single biomarker in detecting HCC,17 and also the competing risk analysis that had mostly confirmed the findings of Cox regression analysis, as GALAD outperformed the detection of HCC. The gene discussed is ACE; the disease is hepatocellular carcinoma.